{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T05:55:56Z","timestamp":1674366956027},"reference-count":19,"publisher":"Japan Neurosurgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2023,1,15]]},"DOI":"10.2176\/jns-nmc.2022-0122","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T22:19:48Z","timestamp":1665613188000},"page":"9-16","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Presentation, Treatment, and Outcome of Nontraumatic Subarachnoid Hemorrhage in Patients with Preceding Antithrombotic Therapy"],"prefix":"10.2176","volume":"63","author":[{"given":"Masaaki","family":"UNO","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"YAGI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"TAKAI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"HIRAI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"MINAMI-OGAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"TAO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"SUNADA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"MATSUBARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dasenbrock HH, Yan SC, Gross BA, et al.: The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: A nationwide inpatient sample analysis. <i>J Neurosurg<\/i> 126: 537-547, 2017","DOI":"10.3171\/2015.12.JNS151107"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Garc\u00eda-Rodr\u00edguez LA, Gaist D, Morton J, Cookson C, Gonz\u00e1lez-P\u00e9rez A: Antithrombotic drugs and risk of hemorrhagic stroke in the general population. <i>Neurology<\/i> 81: 566-574, 2013","DOI":"10.1212\/WNL.0b013e31829e6ffa"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Risselada R, Straatman H, van Kooten F, et al.: Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhage. <i>J Thromb Haemos<\/i> 9: 517-523, 2011","DOI":"10.1111\/j.1538-7836.2010.04170.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Olsen M, Johansen MB, Christensen S, S\u00f8rensen HT: Use of vitamin K antagonists and risk of subarachnoid haemorrhage: A population-based case-control study. <i>Eur J Intern Med<\/i> 21: 297-300, 2010","DOI":"10.1016\/j.ejim.2010.04.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Schmidt M, Johansen MB, Lash TL, Christiansen CF, Christensen S, S\u00f8rensen HT: Antiplatelet drugs and risk of subarachnoid hemorrhage: A population-based case-control study. <i>J Thromb Haemost<\/i> 8: 1468-1474, 2010","DOI":"10.1111\/j.1538-7836.2010.03856.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Potteg\u00e5rd A, Garc\u00eda Rodr\u00edguez LA, Poulsen FR, Hallas J, Gaist D: Antithrombotic drugs and subarachnoid haemorrhage risk. <i>A nationwide case-control study in Denmark Thromb Haemost<\/i> 114: 1064-1075, 2015","DOI":"10.1160\/TH15-04-0316"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Garbe E, Kreisel SH, Behr S: Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use. <i>Stroke<\/i> 44: 2422-2426, 2013","DOI":"10.1161\/STROKEAHA.111.000811"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Amin HZ, Amin LZ, Pradipta A: Takotsubo cardiomyopathy: A brief review. <i>J Med Life<\/i> 13: 3-7, 2020","DOI":"10.25122\/jml-2018-0067"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Toussaint LG 3rd, Friedman JA, Wijdicks EF, et al.: Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. <i>J Neurosurg<\/i> 101: 921-925, 2004","DOI":"10.3171\/jns.2004.101.6.0921"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nilsson OG, Lindgren A, St\u00e5hl N, Brandt L, S\u00e4veland H: Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. <i>J Neurol Neurosurg Psychiatry<\/i> 69: 601-607, 2000","DOI":"10.1136\/jnnp.69.5.601"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Schuss P, Hadjiathanasiou A, Brandecker S, et al.: Anticoagulation therapy in patients suffering from aneurysmal subarachnoid hemorrhage: Influence on functional outcome-a single-center series and multivariate analysis. <i>World Neurosurg<\/i> 99: 348-352, 2017","DOI":"10.1016\/j.wneu.2016.12.036"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rinkel GJ, Prins NE, Algra A: Outcome of aneurysmal subarachnoid hemorrhage in patients on anticoagulant treatment. <i>Stroke<\/i> 28: 6-9, 1997","DOI":"10.1161\/01.STR.28.1.6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Can A, Castro VM, Dligach D, et al.: Elevated international normalized ratio is associated with ruptured aneurysms. <i>Stroke<\/i> 49: 2046-2052, 2018","DOI":"10.1161\/STROKEAHA.118.022412"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hasan DM, Mahaney KB, Brown RD Jr, et al.: Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. <i>Stroke<\/i> 42: 3156-3162, 2011","DOI":"10.1161\/STROKEAHA.111.619411"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gulati S, Solheim O, Carlsen SM, et al.: Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. <i>PLOS ONE<\/i> 13: e0202575, 2018","DOI":"10.1371\/journal.pone.0202575"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Bruder M, Won SY, Wagner M, et al.: Continuous acetylsalicylic acid treatment does not influence bleeding pattern or outcome of aneurysmal subarachnoid hemorrhage: A matched-pair analysis. <i>World Neurosurg<\/i> 113: e122-e128, 2018","DOI":"10.1016\/j.wneu.2018.01.188"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Beynon C, Nofal M, Rizos T, et al.: Anticoagulation reversal with prothrombin complex concentrate in aneurysmal subarachnoid hemorrhage. <i>J Emerg Med<\/i> 49: 778-784, 2015","DOI":"10.1016\/j.jemermed.2015.05.032"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hui FK, Schuette AJ, Moskowitz SI, et al.: Antithrombotic states and outcomes in patients with angiographically negative subarachnoid hemorrhage. <i>Neurosurgery<\/i> 68: 125-130, 2011","DOI":"10.1227\/NEU.0b013e3181fd82b6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gross BA, Rosalind Lai PM, Frerichs KU, Du R: Aspirin and aneurysmal subarachnoid hemorrhage. <i>World Neurosurg<\/i> 82: 1127-1130, 2014","DOI":"10.1016\/j.wneu.2013.03.072"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/63\/1\/63_2022-0122\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T04:24:18Z","timestamp":1674275058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/63\/1\/63_2022-0122\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2022-0122","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,15]]},"article-number":"2022-0122"}}